• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Association of Tripartite Motif Containing 11 rs564309 With Tau Pathology in Progressive Supranuclear Palsy.三肽重复包含蛋白 11 基因 rs564309 与进行性核上性麻痹tau 病理的关联。
Mov Disord. 2020 May;35(5):890-894. doi: 10.1002/mds.28010. Epub 2020 Mar 6.
2
Variation at the TRIM11 locus modifies progressive supranuclear palsy phenotype.TRIM11 基因座的变异可改变进行性核上性麻痹表型。
Ann Neurol. 2018 Oct;84(4):485-496. doi: 10.1002/ana.25308. Epub 2018 Sep 15.
3
Association of MAPT Subhaplotypes With Risk of Progressive Supranuclear Palsy and Severity of Tau Pathology.MAPT 亚单倍型与进行性核上性麻痹风险和 Tau 病理严重程度的关联。
JAMA Neurol. 2019 Jun 1;76(6):710-717. doi: 10.1001/jamaneurol.2019.0250.
4
Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.病理性tau蛋白负荷和分布可将进行性核上性麻痹-帕金森综合征与理查森综合征区分开来。
Brain. 2007 Jun;130(Pt 6):1566-76. doi: 10.1093/brain/awm104.
5
Protracted course progressive supranuclear palsy.进行性核上性麻痹迁延病程。
Eur J Neurol. 2022 Aug;29(8):2220-2231. doi: 10.1111/ene.15346. Epub 2022 Apr 21.
6
Associations of mitochondrial genomic variation with corticobasal degeneration, progressive supranuclear palsy, and neuropathological tau measures.线粒体基因组变异与皮质基底节变性、进行性核上性麻痹和神经病理 tau 测量的关联。
Acta Neuropathol Commun. 2020 Sep 17;8(1):162. doi: 10.1186/s40478-020-01035-z.
7
Latent trait modeling of tau neuropathology in progressive supranuclear palsy.tau 神经病理学在进行性核上性麻痹中的潜在特质建模。
Acta Neuropathol. 2021 May;141(5):667-680. doi: 10.1007/s00401-021-02289-0. Epub 2021 Feb 26.
8
Cognitive impairment in progressive supranuclear palsy is associated with tau burden.进行性核上性麻痹的认知障碍与tau 负担有关。
Mov Disord. 2017 Dec;32(12):1772-1779. doi: 10.1002/mds.27198. Epub 2017 Oct 30.
9
Progressive supranuclear palsy: Neuropathology of patients with a short disease duration due to unexpected death.进行性核上性麻痹:因意外死亡导致病程短的患者的神经病理学
Neuropathology. 2021 Jun;41(3):174-182. doi: 10.1111/neup.12707. Epub 2020 Nov 17.
10
Rainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy.雨水慈善基金会用于进行进行性核上性麻痹神经病理学诊断的标准。
Acta Neuropathol. 2022 Oct;144(4):603-614. doi: 10.1007/s00401-022-02479-4. Epub 2022 Aug 10.

引用本文的文献

1
Multifactorial etiology of progressive supranuclear palsy (PSP): the genetic component.进行性核上性麻痹(PSP)的多因素病因:遗传因素
Acta Neuropathol. 2025 Jun 4;149(1):58. doi: 10.1007/s00401-025-02898-z.
2
It's a TRIM-endous view from the top: the varied roles of TRIpartite Motif proteins in brain development and disease.从顶部俯瞰,这是一幅“超棒”的景象:三联基序蛋白在大脑发育和疾病中的多样作用。 (注:这里“TRIM-endous”是结合“TRIpartite Motif”创造的诙谐表达,翻译时尽量体现出这种趣味性,将其翻译为“超棒” )
Front Mol Neurosci. 2023 Dec 5;16:1287257. doi: 10.3389/fnmol.2023.1287257. eCollection 2023.
3
Tripartite Motif Protein Family in Central Nervous System Diseases.中枢神经系统疾病中的三元基序蛋白家族
Cell Mol Neurobiol. 2023 Aug;43(6):2567-2589. doi: 10.1007/s10571-023-01337-5. Epub 2023 Mar 29.
4
TRIM family proteins: roles in proteostasis and neurodegenerative diseases.TRIM 家族蛋白:在蛋白质平衡和神经退行性疾病中的作用。
Open Biol. 2022 Aug;12(8):220098. doi: 10.1098/rsob.220098. Epub 2022 Aug 10.
5
Tauopathies: new perspectives and challenges.tau 病:新视角与新挑战。
Mol Neurodegener. 2022 Apr 7;17(1):28. doi: 10.1186/s13024-022-00533-z.
6
Protracted course progressive supranuclear palsy.进行性核上性麻痹迁延病程。
Eur J Neurol. 2022 Aug;29(8):2220-2231. doi: 10.1111/ene.15346. Epub 2022 Apr 21.

本文引用的文献

1
The genetic and clinico-pathological profile of early-onset progressive supranuclear palsy.早发性进行性核上性麻痹的遗传和临床病理特征。
Mov Disord. 2019 Sep;34(9):1307-1314. doi: 10.1002/mds.27786. Epub 2019 Jul 12.
2
Association of MAPT Subhaplotypes With Risk of Progressive Supranuclear Palsy and Severity of Tau Pathology.MAPT 亚单倍型与进行性核上性麻痹风险和 Tau 病理严重程度的关联。
JAMA Neurol. 2019 Jun 1;76(6):710-717. doi: 10.1001/jamaneurol.2019.0250.
3
Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy.进行性核上性麻痹诊断标准的敏感性和特异性。
Mov Disord. 2019 Aug;34(8):1144-1153. doi: 10.1002/mds.27619. Epub 2019 Feb 6.
4
APOE ε2 is associated with increased tau pathology in primary tauopathy.载脂蛋白 E ε2 与原发性 tau 病中的 tau 病理增加有关。
Nat Commun. 2018 Oct 22;9(1):4388. doi: 10.1038/s41467-018-06783-0.
5
Variation at the TRIM11 locus modifies progressive supranuclear palsy phenotype.TRIM11 基因座的变异可改变进行性核上性麻痹表型。
Ann Neurol. 2018 Oct;84(4):485-496. doi: 10.1002/ana.25308. Epub 2018 Sep 15.
6
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.进行性核上性麻痹的临床诊断:运动障碍协会标准。
Mov Disord. 2017 Jun;32(6):853-864. doi: 10.1002/mds.26987. Epub 2017 May 3.
7
Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum.跨阿尔茨海默病谱系的β-淀粉样蛋白阶段的临床病理特征及11C-匹兹堡化合物B的意义
Brain. 2015 May;138(Pt 5):1370-81. doi: 10.1093/brain/awv050. Epub 2015 Mar 23.
8
Neuropathology of variants of progressive supranuclear palsy.进行性核上性麻痹的变异型神经病理学。
Curr Opin Neurol. 2010 Aug;23(4):394-400. doi: 10.1097/WCO.0b013e32833be924.
9
Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.病理性tau蛋白负荷和分布可将进行性核上性麻痹-帕金森综合征与理查森综合征区分开来。
Brain. 2007 Jun;130(Pt 6):1566-76. doi: 10.1093/brain/awm104.
10
Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.经病理证实的进行性核上性麻痹的两种不同临床表型的特征:理查森综合征和进行性核上性麻痹-帕金森综合征。
Brain. 2005 Jun;128(Pt 6):1247-58. doi: 10.1093/brain/awh488. Epub 2005 Mar 23.

三肽重复包含蛋白 11 基因 rs564309 与进行性核上性麻痹tau 病理的关联。

Association of Tripartite Motif Containing 11 rs564309 With Tau Pathology in Progressive Supranuclear Palsy.

机构信息

Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.

Division of Biomedical Statistics and Informatics, Mayo Clinic, Jacksonville, Florida, USA.

出版信息

Mov Disord. 2020 May;35(5):890-894. doi: 10.1002/mds.28010. Epub 2020 Mar 6.

DOI:10.1002/mds.28010
PMID:32142177
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7528208/
Abstract

BACKGROUND

Intronic variant rs564309 in tripartite motif containing 11 (TRIM11) is associated with clinical phenotypic differences in progressive supranuclear palsy (PSP), whereby the minor allele (A) is more common in atypical PSP than typical PSP (PSP-Richardson's syndrome). However, rs564309 has not been investigated relative to neuropathological outcomes.

OBJECTIVE

Evaluate the association of rs564309 with the neuropathologically assessed severity of tau pathology, as measured by semi-quantitative scores for neurofibrillary tangles, tufted astrocytes, neuropil threads, and oligodendroglial coiled bodies.

METHODS

797 neuropathologically confirmed PSP cases were genotyped for TRIM11 rs564309 and assessed for tau pathology across 20 neuroanatomical regions. Tau pathology measures and age at death were examined for association with TRIM11 rs564309-A using multivariable linear regression models.

RESULTS

TRIM11 rs564309-A was associated with increased neurofibrillary tangles pathology (P = 0.050), but was not significantly associated with age at death, neuropil threads, coiled bodies, or tufted astrocytes tau pathology scores.

CONCLUSIONS

TRIM11 rs564309 may influence burden of neurofibrillary tangles tau pathology in PSP; further study is warranted. © 2020 International Parkinson and Movement Disorder Society.

摘要

背景

三部分基序蛋白 11(TRIM11)内含子变异 rs564309 与进行性核上性麻痹(PSP)的临床表型差异相关,其中次要等位基因(A)在非典型 PSP 中比典型 PSP(Richardson 综合征)更为常见。然而,尚未针对神经病理学结局对 rs564309 进行研究。

目的

评估 rs564309 与神经病理学评估的 tau 病理学严重程度的相关性,tau 病理学严重程度通过神经原纤维缠结、丛状星形胶质细胞、神经丝缠结和少突胶质细胞螺旋体的半定量评分来衡量。

方法

对 797 例经神经病理学证实的 PSP 病例进行 TRIM11 rs564309 基因分型,并在 20 个神经解剖区域评估 tau 病理学。使用多变量线性回归模型,检查 TRIM11 rs564309-A 与 tau 病理学测量值和死亡年龄之间的关联。

结果

TRIM11 rs564309-A 与神经原纤维缠结病理增加相关(P = 0.050),但与死亡年龄、神经丝缠结、螺旋体或丛状星形胶质细胞 tau 病理学评分无显著相关性。

结论

TRIM11 rs564309 可能影响 PSP 中神经原纤维缠结 tau 病理学的负担;需要进一步研究。